MedStar Georgetown University Hospital is one of the Washington, D.C. area's oldest academic teaching hospitals.

There are 609 beds in MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH).

During the past decade, MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH)" are "Age Related Osteoporosis" (1 trials), "Osteoporosis" (1 trials), "Osteoporosis Localized to Spine" (1 trials), "Osteoporosis Senile" (1 trials) and "Osteoporosis of Vertebrae" (1 trials). Many other conditions were trialed in "MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH)" in a lesser frequency.

Most popular intervention types in "MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH)" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abaloparatide" (1 trials), "Droxidopa capsules" (1 trials), "Placebo" (1 trials) and "Placebo capsules" (1 trials). Other intervention names were less common.

The vast majority of trials in "MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH)" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in MedStar Georgetown-MedStar Georgetown Transplant Institute University Hospital (MGUH), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".